Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran
- 5 September 2019
- journal article
- research article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 47 (3), 220-227
- https://doi.org/10.1159/000501014
Abstract
Purpose: To report the clinical experience and performance of plasma cell-free DNA sequencing-based noninvasive prenatal testing (NIPT) as a screening method in detecting trisomy 21, 18, 13 (T21/T18/T13) as well as sex chromosome aneuploidy (SCA) in a mixed-risk population in Iran. Methods: In a 2-year period between January 1, 2015, and December 31, 2016, over 150 medical centers in Iran offered NIPT as clinical screening tests for fetal T21, T18, T13 and SCA. All NIPT positive cases were recommended to undergo invasive prenatal diagnosis. Results: 11,414 maternal blood samples were received for NIPT, for which 11,223 samples obtained NIPT results. Among 11,213 cases with confirmatory results, 94 T21, 39 T18, 8 T13, 15 XO, 6 XXX, 3 XYY, 5 XXY and 11,042 euploid cases were detected. The overall sensitivity of NIPT was 98.90, 100.00, 100.00, 90.91, 100.00, 100.00 and 100.00%, and specificities were 99.96, 99.97, 99.99, 99.96, 99.98, 100.00 and 99.99% for detecting T21, T18, T13, XO, XXX, XYY and XXY, respectively. Conclusion: With a stringent protocol, our prospective large-scale multicentric nationwide study demonstrated that NIPT showed excellent performance as screening test for the detection of fetal T21, T18, T13 and SCA in mixed-risk pregnancies in Iran.Keywords
This publication has 30 references indexed in Scilit:
- ACMG position statement on prenatal/preconception expanded carrier screeningGenetics in Medicine, 2013
- Feasibility Study of Semiconductor Sequencing for Noninvasive Prenatal Detection of Fetal AneuploidyClinical Chemistry, 2013
- Serum cholesterol and ceruloplasmin levels in second trimester can predict development of pre-eclampsiaNorth American Journal of Medical Sciences, 2013
- Community Genetic Services in IranGenetics Research International, 2012
- Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidiesBMC Medical Genomics, 2012
- Clinical application of massively parallel sequencing‐based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factorsPrenatal Diagnosis, 2012
- Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester populationAmerican Journal of Obstetrics and Gynecology, 2012
- First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective studyUltrasound in Obstetrics & Gynecology, 2011
- Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasmaProceedings of the National Academy of Sciences of the United States of America, 2008
- Population-Based Analyses of Mortality in Trisomy 13 and Trisomy 18Pediatrics, 2003